PMC:7558333 / 10026-10769 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T27","span":{"begin":466,"end":473},"obj":"Body_part"}],"attributes":[{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Demographic, clinical and biological baseline characteristics at admission are detailed in Table 3 and Table S1. Basic demographic characteristics were well-balanced between the three groups of patients (no aspergillosis, Aspergillus colonization, putative/probable aspergillosis). Of note, we observed a high proportion (71.1%) of male patients in the study population. Clinical and biological baseline data did not differ among the three groups, except C-reactive protein which was higher in the “no aspergillosis” group. Regarding the severity scores at admission, no differences were observed either, among the groups of patients, but SAPS II and SOFA scores at day one tended to be higher in patients with putative invasive aspergillosis."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T53","span":{"begin":207,"end":220},"obj":"Disease"},{"id":"T54","span":{"begin":266,"end":279},"obj":"Disease"},{"id":"T55","span":{"begin":502,"end":515},"obj":"Disease"},{"id":"T56","span":{"begin":720,"end":742},"obj":"Disease"},{"id":"T57","span":{"begin":729,"end":742},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"Demographic, clinical and biological baseline characteristics at admission are detailed in Table 3 and Table S1. Basic demographic characteristics were well-balanced between the three groups of patients (no aspergillosis, Aspergillus colonization, putative/probable aspergillosis). Of note, we observed a high proportion (71.1%) of male patients in the study population. Clinical and biological baseline data did not differ among the three groups, except C-reactive protein which was higher in the “no aspergillosis” group. Regarding the severity scores at admission, no differences were observed either, among the groups of patients, but SAPS II and SOFA scores at day one tended to be higher in patients with putative invasive aspergillosis."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T66","span":{"begin":109,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T67","span":{"begin":234,"end":246},"obj":"http://purl.obolibrary.org/obo/UBERON_0001155"},{"id":"T68","span":{"begin":303,"end":304},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T69","span":{"begin":332,"end":336},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T70","span":{"begin":332,"end":336},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"}],"text":"Demographic, clinical and biological baseline characteristics at admission are detailed in Table 3 and Table S1. Basic demographic characteristics were well-balanced between the three groups of patients (no aspergillosis, Aspergillus colonization, putative/probable aspergillosis). Of note, we observed a high proportion (71.1%) of male patients in the study population. Clinical and biological baseline data did not differ among the three groups, except C-reactive protein which was higher in the “no aspergillosis” group. Regarding the severity scores at admission, no differences were observed either, among the groups of patients, but SAPS II and SOFA scores at day one tended to be higher in patients with putative invasive aspergillosis."}

{"project":"LitCovid-sentences","denotations":[{"id":"T80","span":{"begin":0,"end":112},"obj":"Sentence"},{"id":"T81","span":{"begin":113,"end":281},"obj":"Sentence"},{"id":"T82","span":{"begin":282,"end":370},"obj":"Sentence"},{"id":"T83","span":{"begin":371,"end":523},"obj":"Sentence"},{"id":"T84","span":{"begin":524,"end":743},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Demographic, clinical and biological baseline characteristics at admission are detailed in Table 3 and Table S1. Basic demographic characteristics were well-balanced between the three groups of patients (no aspergillosis, Aspergillus colonization, putative/probable aspergillosis). Of note, we observed a high proportion (71.1%) of male patients in the study population. Clinical and biological baseline data did not differ among the three groups, except C-reactive protein which was higher in the “no aspergillosis” group. Regarding the severity scores at admission, no differences were observed either, among the groups of patients, but SAPS II and SOFA scores at day one tended to be higher in patients with putative invasive aspergillosis."}

{"project":"LitCovid-PubTator","denotations":[{"id":"220","span":{"begin":455,"end":473},"obj":"Gene"},{"id":"221","span":{"begin":194,"end":202},"obj":"Species"},{"id":"222","span":{"begin":337,"end":345},"obj":"Species"},{"id":"223","span":{"begin":625,"end":633},"obj":"Species"},{"id":"224","span":{"begin":697,"end":705},"obj":"Species"},{"id":"225","span":{"begin":222,"end":233},"obj":"Species"},{"id":"226","span":{"begin":207,"end":220},"obj":"Disease"},{"id":"227","span":{"begin":266,"end":279},"obj":"Disease"},{"id":"228","span":{"begin":502,"end":515},"obj":"Disease"},{"id":"229","span":{"begin":720,"end":742},"obj":"Disease"}],"attributes":[{"id":"A220","pred":"tao:has_database_id","subj":"220","obj":"Gene:1401"},{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"Tax:9606"},{"id":"A222","pred":"tao:has_database_id","subj":"222","obj":"Tax:9606"},{"id":"A223","pred":"tao:has_database_id","subj":"223","obj":"Tax:9606"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"Tax:9606"},{"id":"A225","pred":"tao:has_database_id","subj":"225","obj":"Tax:746128"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"MESH:D001228"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"MESH:D001228"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"MESH:D001228"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"MESH:D055744"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Demographic, clinical and biological baseline characteristics at admission are detailed in Table 3 and Table S1. Basic demographic characteristics were well-balanced between the three groups of patients (no aspergillosis, Aspergillus colonization, putative/probable aspergillosis). Of note, we observed a high proportion (71.1%) of male patients in the study population. Clinical and biological baseline data did not differ among the three groups, except C-reactive protein which was higher in the “no aspergillosis” group. Regarding the severity scores at admission, no differences were observed either, among the groups of patients, but SAPS II and SOFA scores at day one tended to be higher in patients with putative invasive aspergillosis."}